Table 3.
Variables | Univariate Analysis | Multivariate Analysis |
---|---|---|
aHR (95% CI) | aHR (95% CI) | |
Age at cancer diagnosis (years) | ||
< 35 | 1 (reference) | 1 (reference) |
35-64 | 2.60 (1.34-5.02)* | 2.25 (1.16-4.38)* |
≥ 65 | 5.00 (2.59-9.66)* | 3.66 (1.88-7.12) ** |
Gender (Male vs. Female) | 1.53 (1.36-1.72)* | 1.16 (1.02-1.32)* |
Diabetes mellitus (yes vs. no) | 1.69 (1.50-1.90)* | 1.27 (1.12-1.45) ** |
Hypertension (yes vs. no) | 1.30 (1.14-1.48)* | 0.89 (0.77-1.02) |
Cardiovascular disease (yes vs. no) | 1.54 (1.37-1.74)* | 1.15 (1.01-1.31)* |
Chronic lung disease (yes vs. no) | 1.47 (1.23-1.76)* | 1.17 (0.97-1.40) |
Chronic liver disease (yes vs. no) | 1.34 (1.14-1.58)* | 1.02 (0.85-1.22) |
Cancer site | ||
Kidney | 1 (reference) | 1 (reference) |
Bladder | 1.45 (1.11-1.90)* | 1.38 (1.06-1.81)* |
Liver | 4.37 (3.39-5.62)* | 3.92 (3.02-5.09) ** |
Colon / Rectum | 2.68 (2.02-3.55)* | 2.15 (1.61-2.86) ** |
Lung | 8.81 (6.62-11.72)* | 6.31 (4.70-8.48) ** |
Stomach | 4.85 (3.49-6.75)* | 3.86 (2.76-5.41) ** |
Mouth | 3.57 (2.32-5.48)* | 2.99 (1.96-4.63) ** |
Tongue | 3.57 (2.03-6.30)* | 3.49 (1.97-6.19) ** |
Nasopharynx | 5.64 (3.34-9.52)* | 5.81 (3.42-9.85) ** |
Thyroid | 0.51 (0.19-1.40) | 0.60 (0.22-1.64) |
Prostate | 2.38 (1.48-3.85)* | 1.61 (0.98-2.63) |
Breast | 1.30 (0.90-1.88) | 1.35 (0.93-1.96) |
Cervix | 3.24 (2.21-4.74)* | 2.88 (1.96-4.25) ** |
HR, hazard ratio; CI, confidence interval.
aHR adjusted for gender, age, diabetes mellitus, hypertension, cardiovascular disease, chronic lung disease, and chronic liver disease.
*P<0.05.
**P < 0.001.